Oncology PracticeCabozantinib used as first-line therapy prolongs PFS for metastatic RCCOctober 15, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeAdjuvant sunitinib offers DFS edge in high-risk RCCOctober 14, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeIn favorable intermediate-risk prostate cancer, brachytherapy alone sufficesOctober 6, 2016Genitourinary Cancer
Oncology PracticeHypofractionated RT safe, convenient in low-risk prostate cancerOctober 3, 2016Genitourinary Cancer
The Journal of Community and Supportive OncologyA positive attitude in prostate cancer challenges: finding hope and optimismSeptember 28, 2016Genitourinary CancerPatient & Survivor Care
The Journal of Community and Supportive OncologyEvaluation of a policy of lymph node retrieval for colon cancer specimens: a quality improvement opportunitySeptember 28, 2016Genitourinary Cancer
Oncology Practice10-year follow-up: Localized prostate cancer treatments offer similar efficacySeptember 21, 2016Genitourinary Cancer
Oncology PracticeNo link between vasectomy, prostate cancer in U.S. cohortSeptember 20, 2016Genitourinary Cancer
Oncology PracticeFDA modifies dosage regimen for nivolumabSeptember 19, 2016Lung CancerGenitourinary CancerLymphoma & Plasma Cell DisordersMelanomaRenal Cell Carcinoma
Hematology NewsNew anticancer drugs linked to increased costs, life expectancySeptember 12, 2016Genitourinary CancerPractice ManagementCMLLung CancerBreast CancerLymphoma & Plasma Cell DisordersBusiness of Medicine
Oncology PracticeDrug combo shows promise for non–clear cell renal cell carcinomaSeptember 6, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeStudy supports extending docetaxel therapy in metastatic castration-resistant prostate cancerSeptember 2, 2016Genitourinary Cancer
Oncology PracticeProstate cancer incidence continues to decrease after recommendation against screeningSeptember 1, 2016Genitourinary CancerPreventive Care
